Discover how integrating advanced imaging, digital pathology, and molecular analysis, can refine fibrosis staging and ...

Liver cirrhosis is a late-stage liver disease characterized by the gradual replacement of healthy liver tissue with scar tissue. This condition typically results from long-term chronic hepatitis ...

Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.

Cirrhosis is the last stage of fatty liver disease. Liver cirrhosis can induce swelling in several areas of the body which should not be taken lightly. The development of ascites is a telltale ...

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...

Researchers from Cleveland Clinic have suggested that bariatric surgery is a good treatment option for both cirrhosis and obesity. Senior author Dr Ali Aminian said: “Bariatric surgery was associated ...

Thirty-three patients with liver cirrhosis were investigated ... These changes could be occurring in the early stages of cirrhosis as the incidence and severity of neuropathy was not significantly ...

About 20% of people with MASH can progress to late-stage liver scarring which is called cirrhosis. Approximately three million people in the United States are estimated to have MASH-related cirrhosis.

Akero Therapeutics announced statistically significant results from a Phase 2b trial of efruxifermin this week, a fibroblast ...

Results showing Akero’s efruxifermin improved fibrosis by more than what Wall Street expected lifted the stock of both it and rival MASH developer 89bio.